BioCentury
ARTICLE | Clinical News

Aironite: Phase IIa data

February 8, 2016 8:00 AM UTC

Top-line data from a double-blind, U.S. Phase IIa trial in 30 heart failure patients with preserved ejection fraction showed that 90 mg inhaled AIR001 met the primary endpoint of improving pulmonary c...